True Node Sciences Inc (TNS), a New York-based pharmaceutical and MedTech company, focuses on addressing unmet medical needs in mucosal inflammatory diseases by developing drug products and AI-based diagnostic tools.The company's pharmaceutical unit is committed to innovative drug therapies, while the under formation MedTech division designs AI-driven technologies for early disease diagnosis.Based on a proprietary pharmaceutical platform along with an AI-driven diagnostic tool, TNS pharmaceutical portfolio features products addressing diverse unmet needs, including oral mucositis, periodontitis, ulcerative colitis, and mouth ulcers caused by epidermolysis bullosa.